Dialysis Products No Longer on FDA’s Device Shortage List

The US Food and Drug Administration (FDA) removed two dialysis-related product codes from its device shortage list.

The kidney perfusion system (product code KDN) and disposable kidney perfusion set (product code KDL) had been on the shortage list since January 2022. The FDA blamed the product shortages on a “shortage or discontinuance of a component, part, or accessory of the device” and shipping delays.

Only five product codes remain on the list, including automated external defibrillators and two types of oxygenator devices intended for extracorporeal circulation. Since the end of the COVID-19 public health emergency in May 2023, the FDA no longer requires manufacturers of medical devices to report product shortages; however, the agency encourages voluntary reporting of production interruptions or discontinuations.